logo
Ten trading days that shook financial markets

Ten trading days that shook financial markets

Yahoo11-04-2025

By Tom Westbrook and Dhara Ranasinghe
SINGAPORE/LONDON (Reuters) -The pain, said Shuntaro Takeuchi, was 10 out of 10.
Not in the portfolio of Japanese stocks he runs out of Palo Alto, California, but in his appendix.
It would have to come out, just as his colleagues at Matthews Asia were on a phone call to chart the $7 billion asset manager's path through a deepening market rout.
"I was on a conference call two minutes before the surgery," said Takeuchi. "The nurse was like: 'Do you really have to attend this?'"
In Tokyo, the Nikkei was on its way to Wednesday's 4% drop and trillions were being wiped from global equities, the largest dollar-value drops of any market drawdown on record.
The 10 trading days since U.S. President Donald Trump hit automakers with tariffs have been the most convulsive since the pandemic panic of 2020, as prices of stocks to bonds, oil, gold and even the U.S. dollar itself have swung wildly.
Selling in U.S. Treasuries - the lynchpin safe asset in global markets - was the heaviest for decades, as if to underline how the foundations of trade and finance have been shaken.
The meltdown began in the wake of what Trump called "Liberation Day".
He raised, on April 2, the highest wall of tariffs around the U.S. economy in a hundred years with a blanket 10% tax on imports and even higher rates on individual trading partners.
In the week that has followed that has morphed into open economic conflict with China, which by Friday was all but under a U.S. trade embargo as tariffs rose to 145%.
More than $5 trillion in market value has vanished from the MSCI all-country index of world stocks during the roller-coaster ride since April 2. It has exposed how investors were unprepared for the aggression of Trump's tariffs and that his unpredictability and reversals risk harming the United States' place at the centre of the financial universe.
"We've had a fracturing of confidence and we don't know what the second-order effects of that are from the market falling," said Geoff Wilson, a veteran fund manager in Australia.
"There could be some hedge funds that have gone under, there could be other consequences which will only become clear over the next few weeks." His funds were buyers in the turmoil.
TOMB SWEEPING
At first the epicentre of selling was in any sort of exposure to economic growth - banks, industrial metals and firms such as Apple with supply chains anchored in China.
Then, just before sundown on April 4 in Beijing, on tomb sweeping day - a national holiday to pay respects to ancestors, China retaliated and put a 34% tariff on imports from the U.S.
Oil plunged to a four-year low and the main global stock market index tipped past the threshold for what market-types call a "correction" - a drawdown of 10% or more from a peak.
Even gold, seen as a haven in times of turmoil, started tumbling, an ominous sign as investors who faced margin calls were forced to sell their safest assets to square losses.
For Wong Kok Hoi, founder and chief executive officer of APS Asset Management in Singapore, it was a scenario he has been worrying about for years.
"Obviously, I did not in my wildest dreams think tariff rates could go up as high as 125%," he said, as subsequent days saw tit-for-tat levies ratchet higher.
"Basically, trade will stop between the two largest economies in the world."
Handily, for him, he had positioned into China's semiconductor, artificial intelligence and biotechnology sectors and said his portfolio was up some 20% for the year so far.
TRADE WAR
On Wall Street, bankers dialled in to global meetings and tried to reassure rattled clients.
There were hopes, last weekend, that Trump would relent before the tariffs actually hit.
But returning from a weekend golfing reporters asked him about markets on Air Force One on Sunday and he replied that "sometimes you have to take medicine."
That opened the floodgates. Nasdaq 100 futures were soon down more than 5% and Nikkei futures hit a circuit breaker after diving 8%, then kept falling.
The CBOE Volatility Index, nicknamed Wall Street's "fear gauge", spiked above 60 - a level usually seen during meltdowns such as 2020 or the 2008 financial crisis.
The S&P 500 finished the day 17% below a record high it had hit just seven weeks earlier. Christopher Forbes, head of Asia at CMC Markets said Friday and Monday were the highest volume trading days on record.
Takeuchi, in California, aside from his rush to surgery, was trying to make sure his portfolio was as sheltered as possible.
"We did trade," he said, buying and selling when stocks in his book or watch list hit target or buy prices, finding companies with limited U.S. exposure, but not wanting to make big bets on sectors or the outcome of Trump's trade war.
"I don't want to be too dramatic about it. What we are doing is to not panic, control the risk and focus on stock selection."
BOND FIRE
For months currency markets, as the means of global trade, were expected to be the front line for price adjustments to tariffs.
The shock, instead, came from bonds. Shortly after the tariffs took effect in the middle of the New York night, a massive wave of selling hit Treasuries in Asia on Wednesday.
Yields, which usually make small moves since the market is liquid and deep, rose wildly and unleashed the most manic phase - so far - of markets' tariff tantrum.
The 10-year Treasury yield jumped nearly 20 basis points in two hours in what traders took as a signal of either forced selling somewhere in the market, or even more worryingly, that U.S. bonds were faltering as a safe haven.
But within hours, markets were whipsawed again. Trump stunned the world by announcing a pause on the heavier bilateral tariffs, keeping a blanket 10% tax on imports and raising levies again on China.
Equities roared higher, notching some of the largest percentage gains since 2008, but with so much uncertainty they have started to wobble again.
WHIPLASH
Martin Whetton, Westpac's head of financial markets strategy and a 30-year veteran of markets in Sydney and London, said Wednesday's trade in fixed income had no historical precedent.
"That money did not scramble to secure U.S. dollar funding, to buy Treasuries and the U.S dollar for safety, is startling and a sharp warning," he said.
By Friday, the eleventh session since Trump's auto tariffs were announced, exhaustion had set in but there was little sense of dust settling. Beijing on Friday increased its tariffs on U.S. imports to 125%.
Stocks fell, the dollar sank to a decade-low on the safe-haven Swiss franc and talk turned to whether the period marks the beginning of the end of U.S. dominance of global finance.
"It's like we had a year of trading in a few days," said Jack McIntyre, portfolio manager for Brandywine Global, U.S, which runs almost $60 billion in assets.
"You focus on things that you know," he said, with a view to further falls in the dollar as the U.S. economy slows down and, maybe, the rest of the world keeps selling U.S. assets.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exclusive: Zorro clinches $20M Series A for ICHRA health plans
Exclusive: Zorro clinches $20M Series A for ICHRA health plans

Axios

time20 minutes ago

  • Axios

Exclusive: Zorro clinches $20M Series A for ICHRA health plans

Health benefits provider Zorro raised $20 million in Series A funding led by Entrée Capital, CEO Guy Ezekiel tells Axios exclusively. Why it matters: As employers wrestle with rising health plan costs, individual coverage health reimbursement arrangements (ICHRAs) are gaining steam. Driving the news: Launched in 2020, ICHRAs were enabled by a Trump-era rule letting employers reimburse employees tax-free for individual health insurance instead of offering group plans. After a slow start, rule clarifications and compliance tools made them more accessible to midsized employers. Follow the money: Existing backers Pitango and 10D joined the round, which will be used to scale operations and improve support for employers. The Series A brings Zorro to $31.5 million total raised. The company is not yet profitable. How it works: New York City-based Zorro replaces traditional group plans with defined-contribution models. Employers set a budget; employees use Zorro's AI engine to select personalized plans, and brokers get real-time tools to compare group plans versus ICHRA-based options. When it onboards an employer, Zorro asks them to send their benefits roster from the previous year, asks about quality and budget priorities for the upcoming year, and helps predict what benefits employees might want next. Zorro has "several thousand" lives on the platform, per Ezekiel. Between the lines: Zorro's pitch hinges not just on cost control but on its ability to shift complex decision-making from HR to software — claiming that 75% of users enroll without human help. What they're saying: "We're giving the employer a line of sight to how his upcoming year is going to look," says Ezekiel. Reality check: While ICHRAs are gaining traction, they remain a small fraction of the employer market. Zorro's long-term success depends on widespread broker adoption and employee trust in AI-led benefit decisions. State of play: A February Bailey's report predicted the debut of several new ICHRA startups in 2025. Several others have secured recent funding. In April, Thatch raised $40 million in Series B funding led by Index Ventures and Venteur Health Insurance raised a $20 million Series A led by Informed Ventures and American Family Ventures. Remodel Health last December collected more than $100 million in a round led by Oak HC/FT and Hercules Capital.

Close Trump Allies Sponsored the Military Parade, Raising Ethical Concerns
Close Trump Allies Sponsored the Military Parade, Raising Ethical Concerns

New York Times

timean hour ago

  • New York Times

Close Trump Allies Sponsored the Military Parade, Raising Ethical Concerns

Saturday's military parade in Washington celebrating the 250th anniversary of the U.S. Army was sponsored by at least four brands that have strong financial and political ties to President Trump, raising questions about whether the event benefited his allies and supporters. Attendees who sought relief from the sweltering heat on the National Mall found free cans of a new energy drink brand sponsored by Dana White, who is the chief executive of the Ultimate Fighting Championship and one of Mr. Trump's staunchest allies. Palantir, the data analysis and technology firm whose contracts with the federal government are expanding, and Coinbase, a cryptocurrency firm that donated to the president's inauguration, also sponsored the event. Oracle, a database company whose co-founder is a close friend of Mr. Trump's, received a shout-out on Saturday as a sponsor. U.F.C. was mentioned as a sponsor during the military procession and on the event's website, but its spokesman said in an email statement that the company was not a corporate sponsor and that Mr. White had supported the program in his personal capacity. Federal regulations prohibit the use of public office for the private gain of officeholders or their friends, relatives or nongovernmental affiliates, said Richard W. Painter, who served as the chief ethics lawyer in the White House Counsel's Office under President George W. Bush. 'The parade is being used for advertising by these entities with close business ties to the president,' Mr. Painter said in an interview. 'You're in a situation where the U.S. government has been used to endorse a product.' Want all of The Times? Subscribe.

I tried 2 ways of investing in bitcoin. One thrived and one failed miserably, teaching me a valuable lesson.
I tried 2 ways of investing in bitcoin. One thrived and one failed miserably, teaching me a valuable lesson.

Yahoo

timean hour ago

  • Yahoo

I tried 2 ways of investing in bitcoin. One thrived and one failed miserably, teaching me a valuable lesson.

Last December, I decided to add bitcoin exposure to my portfolio through an ETF and a single stock. The iShares Bitcoin Trust ETF has climbed double digits, while Semler Scientific has underperformed. If you're a crypto beginner looking to get exposure to bitcoin, I recommend sticking to ETFs. Back in December of 2024, I decided to hop aboard the bitcoin train and add some crypto exposure to my portfolio. Markets were flush off of the recent Trump victory, there were whispers of a national bitcoin reserve, and bitcoin had recently broken the $100,000 threshold for the first time. The cryptocurrency had gone mainstream enough for late adopters like myself to deem it investable. For my first foray into bitcoin, I purchased a share of Blackrock's iShares Bitcoin Trust Trust (IBIT). I later added a share of Semler Scientific (SMLR), a healthcare technology company that holds bitcoin on its balance sheet. I wanted to try multiple methods of investing in bitcoin. In hindsight, I realize I committed the classic retail investor impulse: buying in because of FOMO. Sure, positive investor sentiment led to gains in bitcoin, as well as the ETF I bought that was designed to track the crypto. But my stock purchase proved ill-timed. Almost six months later, bitcoin has crossed new all-time-highs, and I have mixed feelings on my investment. I opted to buy IBIT instead of actual spot bitcoin because it was a more accessible way to get exposure. I didn't want the hassle of setting up a Coinbase account. Plus, buying a single share in an ETF was more psychologically appealing than buying a tiny fraction of a bitcoin (I did not have a spare $100,000 or the risk tolerance to buy an entire bitcoin). The performance has been encouraging. Year-to-date, IBIT is up about 14%, outpacing a 12% gain for bitcoin itself. It's done its job of tracking the crypto, and even added a little extra. And it's far outperformed the S&P 500, which is up just 2% in 2025. ETFs can experience slight tracking differences due to management fees, operational costs, and the timing of inflows and outflows. But if you want a rough proxy of bitcoin performance without actually owning the underlying asset, IBIT gets the job done. A year and a half over its launch, IBIT has gained incredible popularity, growing to over $70 billion in assets under management. Robert Cannon, a financial advisor at Experity Wealth with a specialization in alternative assets, recommends his bitcoin-curious clients to start with the ETF. "It's the easiest, cleanest representation of bitcoin, compared to some of the other strategies that are a bit esoteric," Cannon told me. The ETF wrapper has really helped bitcoin adoption take off in the last year, Rahul Sen Sharma, president and co-CEO at the custom index provider Indxx, told me. Sharma's seeing a surge in interest for bitcoin and digital asset ETFs, and he believes Trump's continued support for crypto will pave the way for more mainstream adoption. Getting bitcoin exposure through other methods was indeed more esoteric — and much less profitable. I added Semler Scientific to my portfolio on January 8, 2025, and it's down more than 40% since then. There's a growing trend among companies to add bitcoin to their balance sheets, with Strategy, Tesla, and GameStop being one of the most prominent examples. The president's own Trump Media and Technology Group has recently raised $2.5 billion to buy bitcoin. Semler Scientific started adding bitcoin to its balance sheet in May of last year and now holds over 4,000 bitcoins. It sounds like a good idea in theory: holding bitcoin as a reserve asset could be a hedge against inflation and dollar weakness, and could also lead to capital appreciation as bitcoin takes off. Some companies like Strategy have had tremendous success. The firm has accumulated over half a million bitcoins, and the stock has outperformed the underlying crypto year-to-date. However, it's hard to replicate the scale and expertise of Strategy. While many of Cannon's clients often inquire about bitcoin treasury companies like Strategy, he usually recommends they stick to the basics with an ETF. There were also company-specific headwinds for Semler Scientific. The company had been under investigation from the Department of Justice for allegedly misleading claims about one of its medical devices. My takeaway from the experience is that buying a single stocks as a bitcoin proxy is probably not a good idea. When you buy into a bitcoin treasury company, you're also inheriting all of its company-specific risks. That includes everything from management decisions and financial health to legal exposure, product performance, and market sentiment around the core business. As a result, the benefits of diversification with bitcoin are watered down. If you're looking for bitcoin exposure, either buying the real thing or a spot ETF is your best bet. Maybe the strategy from here on out is to close out of my position in SMLR and do some tax-loss harvesting this year. Read the original article on Business Insider Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store